Cited by 705Bone Metabolism and DiseasesBone health and osteoporosis researchEstrogen and related hormone effects

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α

Open access

Cenci, Simone, Weitzmann, M. Neale, Roggia, Cristiana, Namba, Noriyuki, Novack, Deborah, Woodring, Jessica, Pacifici, Roberto·2000·Journal of Clinical Investigation

DOI 10.1172/jci11066PMC PMC381439

Open this paper in CoChat — free account Open PDF

Abstract

Physiologic osteoclast renewal results from the differentiation of bone marrow monocytes (BMMs) into osteoclasts, a process induced by the simultaneous stimulation of osteoclast precursors by macrophage colonystimulating factor (M-CSF) and a TNF-related factor known as receptor activator of NF-κB ligand (RANKL; also known as OPGL, TRANCE, or ODF) (1-3).Although upregulation of osteoclast formation is recognized as the main mechanism by which estrogen deficiency induces bone loss (4, 5), the responsible cells and cytokines are not completely understood.Bone marrow stromal cells are essential for physiologic osteoclast renewal because they represent a major source of RANKL and M-CSF and provide a physical support for nascent osteoclasts (6).However, in stimulated conditions additional bone marrow cells contribute to regulate osteoclast formation by producing soluble and membrane-bound pro-and antiosteoclastogenic cytokines.Among them are activated T cells, which stimulate osteoclast formation through increased production of RANKL, a phenomenon that contributes to inflammation-induced bone loss (7).T cells express estrogen receptors, and estrogen directly regulates T-cell function and cytokine production (8-11).Moreover, T-cell subset alterations occur in women with postmenopausal osteoporosis (12, 13).Taken together, these findings suggest that T cells may contribute to enhanced osteoclast formation and induce bone loss not only during inflammation, but also in conditions of estrogen deficiency.In this study we have investigated the role of T cells in ovariectomy-induced bone loss.We report that ovariectomy-enhanced T-cell production of TNF-α, which, acting through the TNF-α receptor p55, augments M-CSF-and RANKL-induced osteoclastogenesis.We also show that ovariectomy failed to induce bone loss, stimulate bone resorption, and increase osteoclast formation in T-cell deficient mice, establishing T cells as essential mediators of the bone-wasting effects of estrogen deficiency in vivo. Methods Experimental protocol.All animal procedures were approved by the Animal Care and Use Committee of Barnes-Jewish Hospital.Wild-type C57BL/6 mice, C57BL/6 homozygous (nu/nu) athymic nude mice (14), and heterozygous (nu/+) euthymic control littermates were obtained from Taconic Farms Inc. (Germantown, New York, USA).C57BL/6 mice lacking either TNF-α receptor 1 (p55 -/-) or TNF-α receptor II (p75 -/-) and wild-type controls of the same genetic background were obtained from Jackson Laboratories (Bar Harbor, Maine, USA).At 5 weeks of age mice were either sham operated or ovariectomized (OVX), and either left untreated or treated with 17β estradiol (0.16 µg/d) for 4 weeks as described (15,16).In vitro osteoclast generation, cytokine neutralization, and TNF-α assay.Bone marrow cells were either cultured unfractionated or depleted of stromal cells by adherence for 12 hours.The nonadherent fraction was used as a source of T cells and BMM precursors and was found to

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci11066

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,345
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of Osteoporosis
Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,670
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.
Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.275 · Cited by 1,309
Bone histomorphometry : techniques and interpretation
Recker, R. R. (1983) · CRC Press eBooks · Cited by 1,160

Flagged first, then by citations

Show all 57 references

Research works printed but not linked: 2

Olsen, 1996, Endocr Rev, 17, 369
Fujita, 1984, Miner Electrolyte Metab, 10, 375

Sorted by citations

Items 401–500 of 703

Halofuginone prevents estrogen‐deficient osteoporosis in mice
DeSelm, C. J., Zou, W., & Teitelbaum, S. L. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24185 · Cited by 18
Downregulation of the Inflammatory Response by CORM-3 Results in Protective Effects in a Model of Postmenopausal Arthritis
Ibáñez, L., Alcaraz, M. J., Maicas, N., Guede, D., Caeiro, J. R., Motterlini, R., & Ferrándiz, M. L. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9612-7 · Cited by 18
Unexpected low incidence of vertebral fractures in heart transplant recipients: analysis of bone turnover
Kerschan‐Schindl, K., Ruzicka, M., Mahr, S., Paireder, M., Krestan, C. R., Gleiß, A., Bieglmayer, C., Fialka‐Moser, V., Pacher, R., Grimm, M. F., et al. (2007) · Transplant International · doi:10.1111/j.1432-2277.2007.00598.x · Cited by 18
Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities
Sinden, N., & Stockley, R. A. (2010) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310370631 · Cited by 18
Bone Marrow Adipose Tissue as a Critical Regulator of Postmenopausal Osteoporosis - A Concise Review
Niu, H., Zhou, M., Xu, X., & Xu, X. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s466446 · Cited by 19
Role of the major histocompatibility complex class II protein presentation pathway in bone immunity imbalance in postmenopausal osteoporosis
Wang, X., Zhang, X., Han, Y., Duan, X., Wang, J., Yan, H., Wang, S.-S., Xu, Y., Zhu, Z., Wang, L., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.876067 · Cited by 17
Association of chronic liver disease with bone diseases and muscle weakness
Saeki, C., Saito, M., & Tsubota, A. (2024) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-023-01488-x · Cited by 18
Novel RANK Antagonists for the Treatment of Bone-Resorptive Disease: Theoretical Predictions and Experimental Validation
Télétchéa, S., Stresing, V., Hervouet, S., Baud’huin, M., Heymann, M., Bertho, G., Charrier, C., Ando, K., & Heymann, D. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2170 · Cited by 18
Agonist-like SERM effects on ERα-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterus
Scafonas, A., Reszka, A. A., Kimmel, D. B., Hou, X., Su, Q., Birzin, E. T., Kim, S., Chen, H. Y., Tan, Q., Roher, S. P., et al. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.10.013 · Cited by 17
Bone Loss Among Women Living With HIV
Weitzmann, M. N., Ofotokun, I., Titanji, K., Sharma, A., & Yin, M. T. (2016) · Current HIV/AIDS Reports · doi:10.1007/s11904-016-0336-6 · Cited by 18
Self-citation
Molecular Signaling Pathways and Essential Metabolic Elements in Bone Remodeling: An Implication of Therapeutic Targets for Bone Diseases
Sharma, A., Sharma, L. K., & Goyal, R. (2020) · Current Drug Targets · doi:10.2174/1389450121666200910160404 · Cited by 33
A C >T polymorphism located at position −1 of the Kozak sequence of CD40 gene is associated with low bone mass in Spanish postmenopausal women
Pineda, B., Laporta, P., Hermenegildo, C., Cano, A., & García‐Pérez, M. Á. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0536-4 · Cited by 17
The Physiology and Pathophysiology of the Osteoclast
Peruzzi, B., & Teti, A. M. (2011) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-011-9086-6 · Cited by 19
Alterations in osteocyte mediated osteoclastogenesis during estrogen deficiency and under ROCK-II inhibition: An in vitro study using a novel postmenopausal multicellular niche model
Simfia, I., Schiavi, J., & McNamara, L. M. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112005 · Cited by 17
Osteoclast: Origin and Differentiation
Rubin, J. E., & Greenfield, E. M. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_1 · Cited by 18
Interaction among Cells of Bone, Immune System, and Solid Tumors Leads to Bone Metastases
Roato, I. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/315024 · Cited by 17
Bindarit Reduces Bone Loss in Ovariectomized Mice by Inhibiting CCL2 and CCL7 Expression via the NF‐κB Signaling Pathway
Yuan, S., Hu, H., Wang, X., Yang, J., Rong-ping, Z., Bai, X., & Lai, P. (2022) · Orthopaedic Surgery · doi:10.1111/os.13252 · Cited by 16
Physiological levels of estradiol limit murine osteoarthritis progression
Corciulo, C., Scheffler, J. M., Humeniuk, P., Pons, A. D. C., Stubelius, A., von Mentzer, U., Drevinge, C., Barrett, A., Wüstenhagen, S., POUTANEN, M. H., et al. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0032 · Cited by 16
Prevention of postmenopausal osteoporosis and associated fractures: Clinical evaluation of the choice between estrogen and bisphosphonates
al-Azzawi, F. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802296245 · Cited by 20
DHEA prevents bone loss by suppressing the expansion of CD4+ T cells and TNFa production in the OVX-mouse model for postmenopausal osteoporosis
Zhang, N., Gui, Y., Qiu, X., Tang, W., Li, L., Gober, H.-J., Li, D., & Wang, L. (2016) · BioScience Trends · doi:10.5582/bst.2016.01081 · Cited by 16
Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency
Weitzmann, M. N., Roggia, C., Toraldo, G., Weitzmann, L., & Pacifici, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215687 · Cited by 16
Self-citation
Role of glucocorticoid-induced leucine zipper (GILZ) in inflammatory bone loss
Yang, N.-L., Baban, B., Isales, C., & Shi, X.-L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181133 · Cited by 16
Oestrogen inhibits osteoclast formation induced by periodontal ligament fibroblasts
Wattanaroonwong, N., Schoenmaker, T., de Vries, T. J., & Everts, V. E. (2010) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2010.10.004 · Cited by 16
Utilizing time-lapse micro-CT-correlated bisphosphonate binding kinetics and soft tissue-derived input functions to differentiate site-specific changes in bone metabolism in vivo
Tower, R. J., Campbell, G. M., Müller, M., Glüer, C.-C., & Tiwari, S. (2015) · Bone · doi:10.1016/j.bone.2015.01.009 · Cited by 15
Effects of Estrogens on Osteoimmunology: A Role in Bone Metastasis
Marie, J. C., & Bonnelye, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.899104 · Cited by 15
Effect of Lymphocyte Subsets on Bone Density in Senile Osteoporosis: A Retrospective Study
Peng, C., Guo, Z., Zhao, Y., Li, R., Wang, L., & Gong, W. (2022) · Journal of Immunology Research · doi:10.1155/2022/3337622 · Cited by 15
Local Effects of Steroid Hormones within the Bone Microenvironment
Sandor, L. F., Ragacs, R., & Győri, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417482 · Cited by 14
Genetics and pathogenesis of scoliosis
Petrosyan, E., Fares, J., Ahuja, C. S., Lesniak, M. S., Koski, T. R., Dahdaleh, N. S., & Tecle, N. E. E. (2024) · North American Spine Society Journal (NASSJ) · doi:10.1016/j.xnsj.2024.100556 · Cited by 19
The Effect of Astragalus Extractive on Alveolar Bone Rebuilding Progress of Tooth Extracted Socket of Ovariectomied Rats
Liu, X., Zhang, R., Zhou, Y., Yang, Y., Si, H., Li, X., & Liu, L. (2014) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.4314/ajtcam.v11i5.15 · Cited by 15
Osteoclast Differentiation is Downregulated by Select Polyphenolic Fractions from Dried Plum via Suppression of MAPKs and Nfatc1 in Mouse C57BL/6 Primary Bone Marrow Cells
Graef, J., Rendina-Ruedy, E., Crockett, E. K., Ouyang, P., Wu, L., King, J., Cichewicz, R., Lin, D.-B., Lucas, E., & Smith, B. J. (2017) · Current Developments in Nutrition · doi:10.3945/cdn.117.000406 · Cited by 13
Liver X receptors and skeleton: Current state-of-knowledge
Goel, D., & Vohora, D. (2020) · Bone · doi:10.1016/j.bone.2020.115807 · Cited by 15
Suppression of T cell-induced osteoclast formation
Karieb, S. S., & Fox, S. W. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.140 · Cited by 15
Cytokines and fracture healing
Cho, T., Gerstenfeld, L., Barnes, G., & Einhorn, T. (2001) · Current Opinion in Orthopedics · doi:10.1097/00001433-200110000-00007 · Cited by 20
Lack of NOD2 attenuates ovariectomy-induced bone loss via inhibition of osteoclasts
Ke, K., Sul, O., Chung, S.-W., Suh, J., & Choi, H. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0591 · Cited by 15
Estrogen deprivation does not affect vascular heat shock response in female rats: a comparison with oxidative stress markers
Miragem, A. A., Ludwig, M. S., Heck, T. G., Baldissera, F. G., dos Santos, A. B., Frizzo, M. N., & de Bittencourt, P. I. H. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2472-5 · Cited by 15
Low-dose estradiol and endothelial and inflammatory biomarkers in menopausal overweight/obese women
da Silva, L. H. A., Panazzolo, D. G., Marques, M. F., Souza, M. G. C., Paredes, B. D., Neto, J. F. N., Leão, L. M. C. S. M., Morandi, V., Bouskela, E., & Kraemer‐Aguiar, L. G. (2016) · Climacteric · doi:10.1080/13697137.2016.1180676 · Cited by 14
Pulsed low-dose RANKL as a potential therapeutic for postmenopausal osteoporosis
Cline-Smith, A., Gibbs, J., Shashkova, E. V., Buchwald, Z. S., & Aurora, R. (2016) · JCI Insight · doi:10.1172/jci.insight.88839 · Cited by 15
Sex and Liver Disease: The Necessity of an Overarching Theory to Explain the Effect of Sex on Nonreproductive Functions
Maggi, A. C. (2021) · Endocrinology · doi:10.1210/endocr/bqab229 · Cited by 14
Tumor Microenvironment, Clinical Features, and Advances in Therapy for Bone Metastasis in Gastric Cancer
Sun, P., Antwi, S. O., Sartorius, K., Zheng, X., & Li, X. (2022) · Cancers · doi:10.3390/cancers14194888 · Cited by 14
PC‐PLC is involved in osteoclastogenesis induced by TNF‐α through upregulating IP3R1 expression
Xia, L., Zhang, D.-Y., Wang, C., Wei, F.-C., & Hu, Y.-W. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.015 · Cited by 13
Kobophenol A enhances proliferation of human osteoblast-like cells with activation of the p38 pathway
Kwak, J.-H., Lee, S.-R., Park, H.-J., Byun, H.-E., Sohn, E., Kim, B.-O., Rhee, D., & Pyo, S. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.08.015 · Cited by 14
Local Regulators of Bone
Horowitz, M. C., & Lorenzo, J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00071-9 · Cited by 14
Ovariectomy fails to augment bone resorption and marrow B lymphopoiesis in granulocyte colony-stimulating factor transgenic mice
Oda, T., Wada, T., Kuwabara, H., Sawada, N., Yamashita, T., & Kokai, Y. (2005) · Journal of Orthopaedic Science · doi:10.1007/s00776-004-0851-y · Cited by 14
Total lymphocyte count and femoral bone mineral density in postmenopausal women
Cavanna, A., Mautino, F., Monaco, M. D., Vallero, F., & Monaco, R. D. (2004) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-003-0450-6 · Cited by 14
Progress of research on the gut microbiome and its metabolite short-chain fatty acids in postmenopausal osteoporosis: a literature review
Chen, Y., Xie, Y., & Yu, X. (2025) · Frontiers of Medicine · doi:10.1007/s11684-025-1129-3 · Cited by 16
Advances in immune mechanisms and developing immune-targeted therapies for osteoporosis: A systematic review
Tao, R., Liu, C., Wong, P. Y., Huang, T., Alt, V., Rupp, M., Jantsch, J., Thébault, P., Labat, B., Ladam, G. D., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107835 · Cited by 14
The relationship between pro-resorptive inflammatory cytokines and the effect of high dose vitamin D supplementation on their circulating concentrations
Karim, M. Y., Turner, C., Dalton, N. R., Roplekar, R., Sankaralingam, A., Ewang, M., Fogelman, I., & Hampson, G. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.08.010 · Cited by 14
Endocrine sequelae of hematopoietic stem cell transplantation: Effects on mineral homeostasis and bone metabolism
Miglietta, F., Iamartino, L., Palmini, G., Giusti, F., Marini, F., Iantomasi, T., & Brandi, M. L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1085315 · Cited by 14
Adverse bone health among children and adolescents growing up with HIV
Sudjaritruk, T., & Puthanakit, T. (2015) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)30506-9 · Cited by 13
Redundant let‐7a suppresses the immunomodulatory properties of BMSCs by inhibiting the Fas/FasL system in osteoporosis
Liao, L., Yu, Y., Shao, B.-Y., Su, X.-X., Wang, H., Kuang, H., Jing, H., Situai, Y., Yang, D.-Q., & Jin, Y. (2017) · The FASEB Journal · doi:10.1096/fj.201700885r · Cited by 14
Effects of 12-week combined exercise on RANKL/RANK/OPG signaling and bone-resorption cytokines in healthy college females
Kim, J., Kim, H., & Kim, C. (2019) · Physical Activity and Nutrition · doi:10.20463/jenb.2019.0003 · Cited by 13
Bone and the Immune System
Weitzmann, M. N. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-56192-9_12 · Cited by 13
Self-citation
Cyclic Adenosine Monophosphate (cAMP)‐Dependent Phosphodiesterase Inhibition Promotes Bone Anabolism Through CD8 + T Cell Wnt‐10b Production in Mice
Roser‐Page, S., Weiss, D., Vikulina, T., Yu, M., Pacifici, R., & Weitzmann, M. N. (2022) · JBMR Plus · doi:10.1002/jbm4.10636 · Cited by 12
Self-citation
Low‐Dose Staphylococcal Enterotoxin C2 Mutant Maintains Bone Homeostasis via Regulating Crosstalk between Bone Formation and Host T‐Cell Effector Immunity
Wang, H., Lin, S., Lu, F., Huang, B., Lu, X., Yang, Z., Jiang, Z., Li, Y., Zhang, X., Wang, M., et al. (2023) · Advanced Science · doi:10.1002/advs.202300989 · Cited by 12
Does radiographic emphysema correlate with low bone mineral density?
Bon, J. M. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32834f8194 · Cited by 12
Extracellular Vesicle-Mediated Bone Remodeling and Bone Metastasis: Implications in Prostate Cancer
Patil, K., & Soekmadji, C. (2021) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-67171-6_12 · Cited by 14
The Neuropeptide Vasoactive Intestinal Peptide Levels in Serum are Inversely Related to Disease Severity of Postmenopausal Osteoporosis: A Cross-Sectional Study
Wang, W., Wang, Z.-P., Huang, C., Chen, Y., Yao, W., & Shi, B. (2019) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2019.0041 · Cited by 12
Impact of low bone mass and antiresorptive therapy on antibiotic efficacy in a rat model of orthopedic device‐related infection
Thompson, K., Freitag, L., Styger, U., Camenisch, K., Zeiter, S., Arens, D., Richards, R. G., Moriarty, T. F., & Stadelmann, V. A. (2020) · Journal of Orthopaedic Research® · doi:10.1002/jor.24951 · Cited by 12
Understanding osteoclast formation and function: implications for future therapies for osteoporosis
Zaidi, M., Moonga, B. S., Sun, L., Epstein, S., Huang, C. L.-H., & Abe, E. (2003) · Current Opinion in Orthopedics · doi:10.1097/00001433-200310000-00007 · Cited by 12
Bone Metastasis in Bladder Cancer
Lei, Y., Ai, K., Li, X., Li, Z., & Li, Y. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm13010054 · Cited by 11
Adjuvant Endocrine Therapy and Bone Health in Breast Cancer
Clines, G. A., Choksi, P. U., & Poznak, C. H. V. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-015-0277-9 · Cited by 11
Activated B Lymphocyte Inhibited the Osteoblastogenesis of Bone Mesenchymal Stem Cells by Notch Signaling
Pan, M., Hong, W., Yao, Y., Gao, X., Zhou, Y., Fu, G., Li, Y., Guo, Q., Rao, X., Tang, P., et al. (2019) · Stem Cells International · doi:10.1155/2019/8150123 · Cited by 11
A Screening Model for Probiotics Against Specific Metabolic Diseases Based on Caco-2 Monolayer Membrane
Liu, Y., Jiang, P., Zhu, S., Yu, L., Tian, F., Zhao, J., Zhang, H., Chen, W., & Zhai, Q. (2022) · Engineering · doi:10.1016/j.eng.2022.02.014 · Cited by 10
Anti–NF-κB peptide derived from nuclear acidic protein attenuates ovariectomy-induced osteoporosis in mice
Takami, K., Okamoto, K., Etani, Y., Hirao, M., Miyama, A., Okamura, G., Goshima, A., Miura, T., Kurihara, T., Fukuda, Y., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.171962 · Cited by 11
Hexane Fraction of Turbo brunneus Inhibits Intermediates of RANK-RANKL Signaling Pathway and Prevent Ovariectomy Induced Bone Loss
Chaugule, S. R., Sureshbabu, S. K., Dakave, S., Krishna, C. M., Chaudhari, P. R., Indap, M. M., & Chiplunkar, S. V. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00608 · Cited by 11
Osteogenesis Hormonal Regulation: Review
Мироманов, А. М., & Аркадьевич, Г. К. (2021) · Traumatology and Orthopedics of Russia · doi:10.21823/2311-2905-1609 · Cited by 14
Infliximab acts directly on human osteoclast precursors and enhances osteoclast formation induced by receptor activator of nuclear factor κB ligand in vitro
Takita, C., Fujikawa, Y., Itonaga, I., Taira, H., Kawashima, M., & Torisu, T. (2005) · Modern Rheumatology · doi:10.1007/s10165-004-0373-7 · Cited by 11
The Skeletal Subsystem as an Integrative Physiology Paradigm
Weiss, A., Iqbal, J. Z., Zaidi, N., & Mechanick, J. I. (2010) · Current Osteoporosis Reports · doi:10.1007/s11914-010-0033-0 · Cited by 12
Piper Sarmentosum: A New Hope for the Treatment of Osteoporosis
Ramli, E. S. M., Suhaimi, F. H., Ahmad, F., Shuid, A. N., Mohamad, N., & Soelaiman, I. N. (2013) · Current Drug Targets · doi:10.2174/13894501113146660228 · Cited by 11
Protection against Ovariectomy-Induced Bone Loss by Tranilast
Phan, T. V., Ke, K., Sul, O., Park, Y.-K., Kim, K., Cho, Y.-S., Chung, H., & Choi, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095585 · Cited by 10
Selective estrogen receptor modulator lasofoxifene suppresses spondyloarthritis manifestation and affects characteristics of gut microbiota in zymosan-induced SKG mice
Jeong, H., Kim, I. Y., Bae, E.-K., Jeon, C. H., Ahn, K., & Cha, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-91320-1 · Cited by 10
Interactions Among Osteoblasts, Osteoclasts, and Other Cells in Bone
Martin, T. J., Sims, N. A., & Quinn, J. M. W. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10008-1 · Cited by 11
Antiosteoporosis Activity of New Oriental Medicine Preparation (Kyungokgo Mixed with Water Extract of Hovenia dulcis ) on the Ovariectomized Mice
Hwang, Y.-H., Kim, K., Kim, J.-J., Kang, K.-Y., Lee, S.-J., Jeong, G.-Y., Choi, K., Son, Y., & Yee, S. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/373145 · Cited by 10
The role of 5‐lipoxygenase in Aggregatibacter actinomycetemcomitans‐induced alveolar bone loss
Madeira, M. F. M., Queiroz‐Junior, C. M., Corrêa, J. D., Werneck, S. M. C., Machado, F. S., Cunha, T. M., Garlet, G. P., Teixeira, M. M., Silva, T. A., & Souza, D. G. (2017) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12755 · Cited by 10
ERα expression in T lymphocytes is dispensable for estrogenic effects in bone
Gustafsson, K. L., Nilsson, K. H., Farman, H. H., Andersson, A., Lionikaite, V., Henning, P., Wu, J., Windahl, S. H., Islander, U., Movérare‐Skrtic, S., et al. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0183 · Cited by 10
Estrogen deficiency and the pathogenesis of osteoporosis
Khosla, S., & Pacifici, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00032-0 · Cited by 13
Self-citation
Usefulness of ceruloplasmin testing as a screening methodology for geriatric patients with osteoporosis
Karakaş, E., Yetisgin, A., Çadırcı, D., Sezen, H., Altunbaş, R., Kas, F., Demir, M., & Ulaş, T. (2016) · Journal of Physical Therapy Science · doi:10.1589/jpts.28.235 · Cited by 11
Bu‑Shen‑Ning‑Xin decoction suppresses osteoclastogenesis by modulating RANKL/OPG imbalance in the CD4+ T lymphocytes of ovariectomized mice
Zhang, J., Qiu, X., Zhang, N., Tang, W., Gober, H.-J., Li, D., & Wang, L. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3645 · Cited by 10
Oestrogen-deficiency induces bone loss by modulating CD14+ monocyte and CD4+ T cell DR3 expression and serum TL1A levels
Collins, F. L., Stone, M. D., Turton, J., McCabe, L. R., Wang, E. C. Y., & Williams, A. S. (2019) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-019-2704-z · Cited by 10
Soy isoflavones prevent the ovarian hormone deficiency-associated rise in leukocytes in rats
Soung, D. Y., Khalil, D. A., Arquitt, A. B., Smith, B. J., Hammond, L. J., Droke, E. A., Lucas, E. A., Devareddy, L., & Arjmandi, B. H. (2004) · Phytomedicine · doi:10.1078/0944711041495164 · Cited by 10
Postmenopausal Osteoporosis
Pacifici, R. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50042-8 · Cited by 10
Self-citation
Osteoimmunology: Interactions With the Immune System in Spinal Fusion
Bergin, S. M., Crutcher, C. L., Keeler, C., Rocos, B., Haglund, M. M., Guo, H. M., Gottfried, O. N., Richardson, W. J., & Than, K. D. (2023) · The International Journal of Spine Surgery · doi:10.14444/8556 · Cited by 9
Nrf2 Activation as a Therapeutic Target for Flavonoids in Aging-Related Osteoporosis
Messeha, S. S., Fidudusola, F. F., Gendy, S., Latinwo, L. M., Odewumi, C. O., & Soliman, K. F. A. (2025) · Nutrients · doi:10.3390/nu17020267 · Cited by 9
Adipose Tissue Macrophages as Initiators of Exacerbated Periodontitis in Estrogen‐Deficient Environments via the Amplifier Extracellular Vesicles
Li, D., Yang, T., Li, Y., Lyu, X., Hu, C., Yan, J., & Tan, J. (2025) · Advanced Science · doi:10.1002/advs.202506121 · Cited by 9
Genetic Disorders of Bone or Osteodystrophies of Jaws—A Review
Vammi, S., Bukyya, J. L., Ck, A. A., Tejasvi, M. L. A., Pokala, A., Chanchala, H., Talwade, P., Neela, P. K., Shyamilee, T. K., Oshin, M., et al. (2021) · Global Medical Genetics · doi:10.1055/s-0041-1724105 · Cited by 10
SR-A neutralizing antibody: potential drug candidate for ameliorating osteoclastogenesis in rheumatoid arthritis
Xie, Y., Jiang, X. W., Wang, P., Zheng, X., Song, J., Bai, M., Tang, Y., Fang, X., Jia, Y., Li, Z., et al. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac010 · Cited by 10
A clinical study of a standardized extract of leaves of Dalbergia sissoo (Roxb ex DC) in postmenopausal osteoporosis
Vaidya, R. A., Meeta, Raut, A., Agashe, S., Wajahat, A., Sarada, C., & Vaidya, A. B. (2019) · Journal of Mid-life Health · doi:10.4103/jmh.jmh_22_19 · Cited by 9
Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer
Li, H., Gao, J., & Feng, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1054086 · Cited by 10
Turbo methanol extract inhibits bone resorption through regulation of T cell function
Balakrishnan, B., Indap, M. M., Singh, S. P., Krishna, C. M., & Chiplunkar, S. V. (2013) · Bone · doi:10.1016/j.bone.2013.10.008 · Cited by 9
The Potential of Probiotics as a Therapy for Osteoporosis
Collins, F. L., Rios‐Arce, N. D., Schepper, J. D., Parameswaran, N., & McCabe, L. R. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch9 · Cited by 9
An overview of osteoporosis for the practising prosthodontist
Singh, S. V., & Tripathi, A. (2009) · Gerodontology · doi:10.1111/j.1741-2358.2009.00324.x · Cited by 9
Mechanisms of Estrogen Action in Bone
Pacifici, R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00059-8 · Cited by 9
Self-citation
Estrogen, Bone Homeostasis, and Osteoporosis
Riggs, B. L., Khosla, S., & Melton, L. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50042-2 · Cited by 9
Inhibitory effect of 1,25-dihydroxyvitamin D 3 on Porphyromonas gingivalis -induced inflammation and bone resorption in vivo
Li, Z., Cao, L., Wang, Y., Zhang, Z., Fan, M., & Xu, Q. (2016) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2016.08.029 · Cited by 8
Cellular senescence and aging in bone
Mohan, M., Muthusami, S., Selvamurugan, N., Narasimhan, S., Kumaran, R., & Ramachandran, I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820071-1.00013-x · Cited by 8
Association between body fat and bone mineral density in Korean adults: a cohort study
Yoon, H., Sung, E., Kang, J., Kim, C.-H., Shin, H., Yoo, E., Kim, M.-Y., Lee, M. Y., & Shin, S. H. (2023) · Scientific Reports · doi:10.1038/s41598-023-44537-1 · Cited by 8
Gliotoxin potentiates osteoblast differentiation by inhibiting nuclear factor-κB signaling
Wang, G., ZHANG, X., Yu, B., & REN, K. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3524 · Cited by 8
The pathophysiological basis of bone tissue alterations associated with eating disorders
Greco, E. A., Lenzi, A., & Migliaccio, S. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0006 · Cited by 8
Is IFN-γ involved in bone loss or protection? nothing is simple with cytokines
Ferrari‐Lacraz, S., & Ferrari, S. (2007) · BoneKEy-Osteovision · doi:10.1138/20060251 · Cited by 8
Role of Sex Hormones in Human Body
Aubead, N. M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95778 · Cited by 8

Authors: Cenci, S., Weitzmann, M. N., Roggia, C., Namba, N., Novack, D., Woodring, J., & Pacifici, R.
Affiliations: Barnes-Jewish Hospital (US)
Corresponding author: Pacifici, Roberto
ORCID: Cenci, Simone
Weitzmann, M. Neale
Roggia, Cristiana
Namba, Noriyuki
Novack, Deborah
Pacifici, Roberto
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2000-11-15
Volume: 106
Issue: 10
Pages: 1229-1237
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci11066
PMC: PMC381439
OpenAlex: W2133281510
Cited by: 705
References: 57
Citations by year: 2026: 30 · 2025: 30 · 2024: 14 · 2023: 25 · 2022: 23 · 2021: 27 · 2020: 35 · 2019: 25 · 2018: 19 · 2017: 34 · 2016: 33 · 2015: 37 · 2014: 32 · 2013: 32 · 2012: 28
FWCI: 7.12
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Arthritis Foundation
Eli Lilly and Company
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR041412, AR41412, AR-13534)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords: estrogen deficiency, bone loss, ovariectomy, T cells, TNF-α, osteoclastogenesis, RANKL, macrophage colony-stimulating factor, TNF receptor p55, postmenopausal osteoporosis, bone resorption, nude mice, estrogen receptor, mesenchymal stem cells, T cell deficiency
MeSH terms: Animals, Bone Resorption, Carrier Proteins, Cells, Cultured, Estrogens, Membrane Glycoproteins, Mice, Inbred C57BL, Mice, Nude, Osteoclasts, Ovariectomy, T-Lymphocytes, Tumor Necrosis Factor-alpha, Antigens, CD, Macrophage Colony-Stimulating Factor, Receptors, Tumor Necrosis Factor, Mice, Knockout, Receptors, Tumor Necrosis Factor, Type I, Receptors, Tumor Necrosis Factor, Type II, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks